Document is current
Any future updates will be listed below
-
Authors
Golick, Lena https://orcid.org/0000-0003-0669-8190
Robinson, Reeder M.
Reyes, Leticia
St. Thomas, Nadia
Klinzing, Kathleen
O’Connor, Erin C. https://orcid.org/0009-0006-3247-6734
Ferreira, Leonardo M. R. https://orcid.org/0000-0003-2491-9866
Dolloff, Nathan G. https://orcid.org/0000-0002-9181-2180
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA245081, R42CA268138, R44CA268138, R01CA245081, R42CA268138, R44CA268138, R01CA245081, R42CA268138, R44CA268138, R01CA245081, R42CA268138, R44CA268138, R01CA245081, R42CA268138, R44CA268138, R01CA245081, R42CA268138, R44CA268138)
- License Information
-
More Information
Article History
Received: 25 March 2025
Revised: 17 September 2025
Accepted: 9 October 2025
First Online: 17 November 2025
Competing interests
: L.G., R.M.R., and N.G.D. are the inventors of the patents associated with this study. N.G.D. is the founder of Leukogene Therapeutics, Inc and owns shares in the company.
